Intellipharmaceutics International Incorporation operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Intellipharmaceutics International Incorporation with three other companies in this sector in CANADA : Acerus Pharmaceuticals Corporation (2019 sales of 4.99 million Canadian Dollars [US$3.78 million] of which 100% was Pharmacueticals), Polydex Pharmaceuticals Limited (6.46 million Canadian Dollars [US$4.90 million] ), and Spectral Medical Inc (2.87 million Canadian Dollars [US$2.17 million] of which 22% was Proprietary biochemicals).

Sales Analysis. Intellipharmaceutics International Incorporation reported sales of C$4.62 million (US$3.51 million) for the fiscal year ending November of 2019. This represents an increase of 109.2% versus 2018, when the company's sales were C$2.21 million. Despite this increase, sales are still well below the level achieved in 2017, when Intellipharmaceutics International Incorporation reported sales of C$7.17 million.